Professor John Axford - Professor of Rheumatology (MD., DSc, F.R.C.P.)

Professor John Axford studied medicine at University College, London in 1989. He was chosen as a Fulbright Scholar and performed research in various areas of immunology both at the Middlesex Hospital Medical School, and Tufts University, USA. In 1990, Professor Axford completed his research thesis in arthritic diseases and in 1991 was awarded his M.D. with a Specialist Accreditation in Rheumatology and Immunology.

He has lectured extensively throughout the United States, the United Kingdom, Europe, Australia, and Asia and has authored or co-authored over 80 published peer-reviewed scientific papers, over 128 published abstracts and letters, and 18 medical textbooks. Professor Axford is a past section President of the Royal Society of Medicine and currently serves on the Editorial Boards of three medical journals and on numerous medical and health related committees. He is also Editor of the Undergraduate textbook 'Medicine'.

At present, Professor Axford is the Professor of Clinical Rheumatology and the Director of Sir Joseph Hotung Centre for Musculoskeletal Disorders for St George's University of London, where he directs the provision of clinical and basic scientific research, clinical care and both undergraduate and postgraduate education. He joined St George's University of London in 1990 and was appointed Chair of Clinical Rheumatology in 2005.

Currently, Professor Axford is serving as the Principal Investigator for 2 three-year clinical trials funded by St. George's University of London and NHS Hospital.

Back to experts

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event